Ledger.Open graph →
SEC Form D · filed February 27, 2019

GENOCEA BIOSCIENCES, INC

Offering
$15.0M
Sold
$12.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (31)

Derek Meisner · Cambridge, MAExecAli Behbahani · South San Francisco, CADirectorMichael Higgins · HOUSTON, TXDirectorThomas Davis · Hamilton HM 12, BermudaExecGeorge Siber · North Cambridge, MADirectorWilliam Clark · ALEXANDRIA, VAExecKenneth Bate · Cambridge, MADirectorNarinder Singh · San Mateo, CAExecMichael Alfieri · Cambridge, MAExecKatrine Bosley · Waltham, MADirectorJessica Flechtner · Cambridge, MAExecAli Behbahani · Timonium, MDDirectorGirish Aakalu · Cambridge, MAExecRonald Cooper · Cambridge, MADirectorPamela Carroll · Cambridge, MAExecHoward Mayer · Cambridge, MADirectorNarinder Singh · Cambridge, MAExecDerek Meisner · Cambridge, MAExecMichael Alfieri · Cambridge, MAExecKatrine Bosley · Cambridge, MADirectorJessica Flechtner · Cambridge, MAExecAli Behbahani · Seattle, WADirectorGirish Aakalu · Cambridge, MAExecRonald Cooper · Cambridge, MADirectorMichael Higgins · London, United KingdomDirectorThomas Davis · Hamilton HM CX, BermudaExecGeorge Siber · CAMBRIDGE, MADirectorWilliam Clark · Toronto, Ontario, CanadaExecKenneth Bate · Cambridge, MADirectorPamela Carroll · Cambridge, MAExecHoward Mayer · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗